Skip to main content
Veterinary Medicines

Carprogesic 50 mg Tablets for dogs

Authorised
  • Carprofen

Product identification

Medicine name:
Carprogesic 50 mg Tablets for dogs
Carprogesic 50 mg Tablets for dogs
Active substance:
  • Carprofen
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Carprofen
    50.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM01AE91
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • Polypropylene snap secure tubs sealed with cotton wool and white polyethylenesnap secure caps in tubs of 100.
  • Polypropylene snap secure tubs sealed with cotton wool and white polyethylenesnap secure caps in tubs of 500.
  • Alu/Alu blister strips containing 10 (50 mg) tablets per strip in cartons of 20 tablets.
  • Alu/Alu blister strips containing 10 (50 mg) tablets per strip in cartons of 100 tablets.
  • Alu/Alu blister strips containing 10 (50 mg) tablets per strip in cartons of 500 tablets.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Norbrook Laboratories (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Norbrook Manufacturing Ltd
  • Norbrook Laboratories Limited
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA22664/079/002
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0208/002
Concerned member states:
  • Italy
  • Portugal
  • Spain

Documents

Summary of Product Characteristics

English (PDF)
Published on: 16/03/2025
Download

Combined File of all Documents

English (PDF)
Published on: 16/03/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."